PositiveID

Biological Detection and Diagnostics

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.

Click here to view our products

Recent News

January 27, 2015
PositiveID Corporation to Host Shareholder Call and Webcast on January 28, 2015
more
January 20, 2015
PositiveID Corporation Prepares Additional M-BAND Systems for Field Deployment and Testing
more
January 13, 2015
PositiveID Corporation Completes Milestone in Development of Its Firefly Dx Prototype
more
January 6, 2015
PositiveID Corporation's Chairman and CEO Releases Letter to Stockholders
more
December 23, 2014
PositiveID Publishes Year-End Update Report on Market Opportunities for Its Bio-Threat Detection and Diagnostics Solutions
more
View Archives

PositiveID Corporation™ (OTCQB: PSID)

PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.



Click here to watch the video



Click here to watch the video

M-BAND

PositiveID specializes in airborne pathogen detection, rapid clinical diagnostics and sample preparation applications. more

Company report

PositiveID and Secure Strategy Group have published a report on PositiveID. more

Firefly

PositiveID is developing a portable, handheld biological detection system. more

PositiveID™ Corporation, 2015 - All Rights Reserved